A Value-Based Care Future Depends On Precision Medicine Scalability

Each individual is uniquely shaped by their biology and environment. Contemporary healthcare delivery organizations (HDOs) now harness advanced technologies such as big data, genomics, artificial intelligence (AI), and machine learning (ML) to delve into intricate aspects of a person's health, including behaviors, socioeconomic factors, clinical and claims data, and even DNA. This approach, known as precision medicine, is paramount for thriving in healthcare's future anchored in value-based care (VBC), where reimbursement is tied to patient outcomes. When HDOs are incentivized to enhance health outcomes, they have a compelling motive to invest in technology, resources, and care models that prioritize preventive and individualized care. Therefore, the question arises: Can we expand precision medicine while simultaneously reducing healthcare costs for millions of patients? Previously, it seemed like a choice between population health management and personalized care, but contemporary technology enables us to pursue both concurrently.